Browsing Cleaning Systems
Insufficient or inadequate cleaning can have various consequences. From a health point of view, an absence of good cleaning can lead to contaminated drugs with a risk for patients, but also for the workers within the pharmaceutical company due to a lack of correct protection. The ecological problems can be summarized in pollution risks. The regulatory issues are linked with warnings from agencies up to possible authorization withdrawn. Economic problems start with a diminution of production and stock shortage which imply increased internal costs and financial loss. In addition, image problems for a company exist when patients must return medications to the pharmacy as in the case of batch recall.
Contamination is a process with three main factors: the source of contamination (i.e. previous API or excipients, cleaning agents), the vector (for example, unclean apparatus or co-workers), and the receptor (for example, the next batch). Numerous solutions exist to break the links between the factors, and cleaning is one of the most critical. Cleaning should be efficient in all parts of the equipment, but also in rooms and for all the parts or places in which contamination could exist. Some zones which are not easy to clean (O rings, U-bend, etc.) are often called critical points that are defined as “zones or spots in systems on which an absence of control will bring an unacceptable risk for security.
2594 Half Moon Bay Road
Ottawa ON
Canada K2J 0Z1
NORTH AMERICA
Suppliers in Canada
195 Skunk Lane
Cutchogue, NY
United States 11935
NORTH AMERICA
Pharmaceutical Cleanroom Supplies, Apparel and Disinfectants
620 Hearst Ave
United States 94710
NORTH AMERICA
Cleanroom and control environment testing services
A perfect Pharmaceutical buyers/suppliers directory
04-02-20161360 Union Hill Rd, 4G Alpharetta, GA 30004
United States 30004
NORTH AMERICA
EOC1 provides unparalleled testing services to
(369 views since 08-12-2019 11:35AM)
Im Neuenheimer Feld 515
Germany
69120
EUROPE
Analytical Services for Biological Assays
(203 views since 04-12-2016 12:22PM)
18 Z.I. de la Trésorerie
France
62126
EUROPE
Packaging and Equipment for the Pharmaceutical
(213 views since 04-14-2016 07:15AM)
Disease/Medical Use: Diabetes mellitus type 1 and
Disease/Medical Use: Multiple sclerosis
Disease/Medical Use: Erectile dysfunction
Disease/Medical Use: Cholesterol
Disease/Medical Use: Cholesterol
High purity of pharmaceutical intermediates
Name: 2-Methyl-4-(Trifluoromethyl) thiazole-5-carboxylic acidCas No: 117724-63-7Appearance: White to off-white powderPurity: 96.3%Molecular formula
Name: 2,6-Dibromo-4-(Trifluoromethoxy) AnilineCas No: 88149-49-9Purity: 99.82%Appearance: White to off-white powderMolecular formula: